Dai Hashimoto

3.3k total citations
86 papers, 2.2k citations indexed

About

Dai Hashimoto is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Epidemiology. According to data from OpenAlex, Dai Hashimoto has authored 86 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Pulmonary and Respiratory Medicine, 29 papers in Physiology and 22 papers in Epidemiology. Recurrent topics in Dai Hashimoto's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (38 papers), Sarcoidosis and Beryllium Toxicity Research (15 papers) and Asthma and respiratory diseases (12 papers). Dai Hashimoto is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (38 papers), Sarcoidosis and Beryllium Toxicity Research (15 papers) and Asthma and respiratory diseases (12 papers). Dai Hashimoto collaborates with scholars based in Japan, United States and India. Dai Hashimoto's co-authors include Naoki Inui, Takafumi Suda, Yutaro Nakamura, Tomoyuki Fujisawa, Noriyuki Enomoto, Kingo Chida, Hirotoshi Nakamura, Masato Kono, Tateaki Naito and Hironao Hozumi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Radiology.

In The Last Decade

Dai Hashimoto

81 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dai Hashimoto Japan 24 1.5k 692 580 320 242 86 2.2k
Tomohisa Baba Japan 26 1.7k 1.1× 592 0.9× 389 0.7× 197 0.6× 153 0.6× 185 2.2k
Stefania Cerri Italy 29 1.4k 0.9× 559 0.8× 504 0.9× 211 0.7× 510 2.1× 95 2.3k
Shiro Imokawa Japan 21 1.2k 0.8× 514 0.7× 353 0.6× 243 0.8× 103 0.4× 100 1.6k
Eric B. Suhler United States 40 872 0.6× 377 0.5× 477 0.8× 1.6k 5.1× 243 1.0× 143 4.9k
Yutaka Sugita Japan 19 1.1k 0.7× 442 0.6× 755 1.3× 167 0.5× 83 0.3× 132 1.9k
Biman Saikia India 18 632 0.4× 549 0.8× 263 0.5× 167 0.5× 203 0.8× 87 1.4k
Yasuyuki Yoshizawa Japan 23 1.4k 0.9× 400 0.6× 253 0.4× 164 0.5× 207 0.9× 110 1.9k
Janne Björkander Sweden 28 667 0.4× 234 0.3× 563 1.0× 135 0.4× 2.4k 9.9× 92 3.2k
Laurence Gérard France 25 319 0.2× 267 0.4× 545 0.9× 171 0.5× 876 3.6× 65 2.6k
Louis E. Siltzbach United States 23 1.0k 0.7× 1.6k 2.3× 415 0.7× 257 0.8× 209 0.9× 59 2.4k

Countries citing papers authored by Dai Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Dai Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dai Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dai Hashimoto more than expected).

Fields of papers citing papers by Dai Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dai Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dai Hashimoto. The network helps show where Dai Hashimoto may publish in the future.

Co-authorship network of co-authors of Dai Hashimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Dai Hashimoto. A scholar is included among the top collaborators of Dai Hashimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dai Hashimoto. Dai Hashimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Yuzo, Yuko Tanaka, Koshi Yokomura, et al.. (2024). 3D-CT-derived lung volumes and mortality risk in patients with fibrotic hypersensitivity pneumonitis. Allergology International. 74(1). 78–85. 2 indexed citations
2.
Suzuki, Yuzo, Masato Kono, Hirotsugu Hasegawa, et al.. (2023). Neutrophil–lymphocyte ratio in patients with idiopathic pleuroparenchymal fibroelastosis. BMJ Open Respiratory Research. 10(1). e001763–e001763. 6 indexed citations
3.
Suzuki, Yuzo, Masato Kono, Hirotsugu Hasegawa, et al.. (2023). Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis. Respirology. 28(8). 775–783. 23 indexed citations
4.
Karayama, Masato, Takahito Suzuki, Kazutaka Mori, et al.. (2023). A predictive model for acute exacerbation of idiopathic interstitial pneumonias. European Respiratory Journal. 61(5). 2201634–2201634. 5 indexed citations
5.
Yamashita, Toshihiko, et al.. (2021). Usefulness of Near-Infrared Imaging for Intraoperative Parathyroid Detection. 124(8). 1202–1207. 1 indexed citations
6.
Karayama, Masato, Naoki Inui, Hideki Yasui, et al.. (2020). Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutations. Investigational New Drugs. 39(1). 210–216. 6 indexed citations
7.
Kono, Masato, Yutaro Nakamura, Noriyuki Enomoto, et al.. (2019). Prognostic impact of an early marginal decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidone. Respiratory Investigation. 57(6). 552–560. 8 indexed citations
8.
Mori, Kazutaka, Tomoyuki Fujisawa, Naoki Inui, et al.. (2016). Step-down treatment from medium-dosage of budesonide/formoterol in controlled asthma. Respiratory Medicine. 119. 1–6. 9 indexed citations
9.
Fujisawa, Tomoyuki, Hironao Hozumi, Masato Kono, et al.. (2014). Prognostic Factors for Myositis-Associated Interstitial Lung Disease. PLoS ONE. 9(6). e98824–e98824. 134 indexed citations
10.
Hozumi, Hironao, Yutaro Nakamura, Takeshi Johkoh, et al.. (2013). Acute exacerbation in rheumatoid arthritis-associated interstitial lung disease: a retrospective case control study. BMJ Open. 3(9). e003132–e003132. 115 indexed citations
11.
Nakamura, Yutaro, Takafumi Suda, Yusuke Kaida, et al.. (2012). Rheumatoid lung disease: Prognostic analysis of 54 biopsy-proven cases. Respiratory Medicine. 106(8). 1164–1169. 60 indexed citations
12.
Yasui, Hideki, Tomoyuki Fujisawa, Naoki Inui, et al.. (2012). Impact of add-on pranlukast in stable asthma; the additive effect on peripheral airway inflammation. Respiratory Medicine. 106(4). 508–514. 18 indexed citations
13.
Furuhashi, Kazuki, Takafumi Suda, Hirotsugu Hasegawa, et al.. (2011). Mouse Lung CD103+ and CD11bhigh Dendritic Cells Preferentially Induce Distinct CD4+ T-Cell Responses. American Journal of Respiratory Cell and Molecular Biology. 46(2). 165–172. 91 indexed citations
14.
Furuhashi, Kazuki, Takafumi Suda, Yutaro Nakamura, et al.. (2010). Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respiratory Medicine. 104(8). 1204–1210. 91 indexed citations
15.
Yamamoto, Kazumichi, et al.. (2010). Surgical treatment for subglottic stenosis. The Journal of the Japanese Association for Chest Surgery. 24(1). 101–104.
16.
Suda, Takafumi, Masato Kono, Yutaro Nakamura, et al.. (2010). Distinct prognosis of idiopathic nonspecific interstitial pneumonia (NSIP) fulfilling criteria for undifferentiated connective tissue disease (UCTD). Respiratory Medicine. 104(10). 1527–1534. 40 indexed citations
17.
Suda, Takafumi, Yusuke Kaida, Yutaro Nakamura, et al.. (2009). Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases. Respiratory Medicine. 103(6). 846–853. 155 indexed citations
18.
Ozawa, Yuichi, Takafumi Suda, Tateaki Naito, et al.. (2009). Cumulative incidence of and predictive factors for lung cancer in IPF. Respirology. 14(5). 723–728. 221 indexed citations
19.
Hashimoto, Dai, Toshi Nagata, Masato Uchijima, et al.. (2008). Intratracheal administration of third-generation lentivirus vector encoding MPT51 from Mycobacterium tuberculosis induces specific CD8+ T-cell responses in the lung. Vaccine. 26(40). 5095–5100. 13 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomohisa Baba Breakdown of academic impact, for papers by Stefania Cerri Breakdown of academic impact, for papers by Shiro Imokawa Breakdown of academic impact, for papers by Eric B. Suhler Breakdown of academic impact, for papers by Yutaka Sugita Breakdown of academic impact, for papers by Biman Saikia Breakdown of academic impact, for papers by Yasuyuki Yoshizawa Breakdown of academic impact, for papers by Janne Björkander Breakdown of academic impact, for papers by Laurence Gérard Breakdown of academic impact, for papers by Louis E. Siltzbach
Rankless by CCL
2026